Features

FDA approves Dupixent (dupilumab) as treatment for chronic rhinosinusitis

Chronic rhinosinusitis (CRS) is a clinical condition characterized by prolonged inflammation (more than 12 weeks) of the nose and paranasal sinuses. Signs and symptoms of sinusitis include headache, swelling of face, facial pain, nasal discharge, dizziness, and breathing difficulties. Sinusitis is caused by allergies, bacterial and viral infections and presence of nasal polyps (growths on

NICE guidelines for Cochlear implantation in children and adults

The National Institute for Health and Care Excellence (NICE) is a non-departmental public body in England, that provides national guidance and advice to improve health and social care. On 7th March 2019, NICE released an update for the 2009 cochlear implantation guidelines in children and adults with hearing loss. Cochlear implants are electronic prosthetic devices